N/A
N=29
Motivational Strategies To Empower African Americans To Improve Dialysis Adherence
End Stage Renal Disease on Dialysis
Bottom Line
View on ClinicalTrials.gov: NCT05003115 ↗Enrolled (actual)
29
Serious AEs
0.0%
Results posted
Mar 2024
Primary outcome: Primary: Dialysis Treatment Adherence — 95.85; 93.26 percentage of minutes completed — p=0.101
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Motivational interviewing (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Vanderbilt University Medical Center
- Primary completion
- Jan 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Dialysis Treatment Adherence |
95.85; 93.26 | 0.101 |
| SECONDARY Change in Autonomous Regulation |
7.0; 6.8 | 0.78 |
| SECONDARY Change in Autonomy Support |
7.0; 5.2 | 0.314 |
| SECONDARY Change in Perceived Competence |
38; 34 | 0.679 |
| SECONDARY Change in Apathy |
26; 26 | 0.994 |
| SECONDARY Change in Optimism |
24; 22 | 0.258 |
| SECONDARY Perceived Expectancies Index |
43; 40 | 0.857 |
Summary
This study addresses the need to rigorously advance the science and understanding of the development, feasibility, acceptability and adoption of novel culturally-sensitive motivational strategies to improve dialysis treatment adherence among African Americans with end-stage kidney disease (ESKD). This study specifically aims to:
1. Gain advanced skills in the development and implementation of novel culturally sensitive motivational strategies
2. Acquire critical preliminary data for an R01-funded phase II efficacy trial testing the use of these motivational strategies to improve dialysis treatment adherence.
Eligibility Criteria
Inclusion Criteria
- African American
- Receiving hemodialysis treatments
- Been on hemodialysis for more than 30 days
- 18 years of age and older
- Within a 3-month look back at the time of screening, patients who have missed at least one dialysis session or shortened at least one dialysis session by 15 minutes.
Exclusion Criteria
- Not self-identified as African American
- Impaired with mental status or severe illness
- Non-English speaking
- No documented evidence of dialysis treatment non-adherence
- Missed or shortened treatments due to hospitalizations or excused travel
- Terminal condition
- Living in a nursing home/rehab
- Planned transplant within the next 3 months
- Planned conversion to peritoneal dialysis within the next 3 months
Data sourced from ClinicalTrials.gov (NCT05003115). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.